Robert Malone: In Canada, there is speculation that Justin Trudeau and his family’s foundation holds 40% of private biotech company Acuitas Therapeutics, which has designed lipid nanoparticle delivery systems for both the Pfizer-BioNTech vaccine Comirnaty and CureVac’s vaccine programs.
“There appears that there may be a major financial conflict of interest on the part of Mr. Trudeau.”